Liraglutide attenuates doxorubicin-induced cardiomyocyte ferroptosis via DHHC7-mediated STAT3 palmitoylation.

Liraglutide 透過 DHHC7 介導的 STAT3 棕櫚醯化，減輕 doxorubicin 誘導的心肌細胞鐵死亡。